MarketCap
Facebook
X
TelegramQuartalsbericht 2022-Q4
hinzugefügt 09.02.2023
Land |
 Vereinigte Staaten |
IPO-Jahr |
1986 |
Branche |
Diagnostik & Forschung |
Börse |
NASDAQ GLOBAL |
Anteile |
43.6 M |
Marktkapitalisierung |
$ 1.49 B |
EBITDA (LTM) |
$ 52.9 M |
P/E (LTM) |
- |
P/S (LTM) |
4.65 |
EPS (LTM) |
0.6 |
Andere Aktien der Branche "Diagnostik & Forschung"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
 |
Agilent Technologies
A
|
$ 117.53 | 4.77 % | $ 35.7 B | NYSE,SPB | USA |
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
CareDx, Inc
CDNA
|
$ 20.7 | -1.24 % | $ 1.1 B | Nasdaq Global Market,SPB | USA |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market |  Israel |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
Co-Diagnostics
CODX
|
$ 1.59 | 1.27 % | $ 2.12 M | Nasdaq Capital Market | USA |
 |
Castle Biosciences
CSTL
|
$ 24.6 | -3.61 % | $ 683 M | Nasdaq Global Market,SPB | USA |
 |
Koninklijke Philips N.V.
PHG
|
$ 26.45 | 0.8 % | $ 20 B | NYSE |  Niderland |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE |  China |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
Charles River Laboratories International
CRL
|
$ 185.39 | 7.58 % | $ 9.19 B | NYSE,SPB | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | USA |
 |
Fulgent Genetics
FLGT
|
$ 14.9 | -1.46 % | $ 451 M | Nasdaq Global Market | USA |
 |
Guardant Health
GH
|
$ 89.52 | -1.81 % | $ 11.2 B | Nasdaq Global Select Market,SPB | USA |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
ICON Public Limited Company
ICLR
|
$ 121.32 | 8.35 % | $ 10 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
Illumina
ILMN
|
$ 139.07 | -0.22 % | $ 22.1 B | Nasdaq Global Select Market,SPB | USA |
 |
Interpace Biosciences
IDXG
|
$ 2.01 | 0.4 % | $ 8.89 M | Nasdaq Global Select Market | USA |
 |
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | Niderland |
 |
Biomerica
BMRA
|
$ 2.19 | 1.16 % | $ 5.03 M | Nasdaq Capital Market | USA |
 |
Lantheus Holdings
LNTH
|
$ 85.82 | -2.23 % | $ 5.79 B | Nasdaq Global Select Market,SPB | USA |
 |
Laboratory Corporation of America Holdings
LH
|
$ 257.14 | 1.64 % | $ 21.4 B | NYSE,SPB | USA |
 |
Medpace Holdings
MEDP
|
$ 430.32 | 3.19 % | $ 12.4 B | Nasdaq Global Select Market,SPB | USA |
 |
Celcuity
CELC
|
$ 141.69 | -2.27 % | $ 6.63 B | Nasdaq Global Select Market | USA |
 |
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | Israel |
 |
Myriad Genetics
MYGN
|
$ 5.03 | 1.82 % | $ 466 M | Nasdaq Global Select Market,SPB | USA |
 |
Burning Rock Biotech Limited
BNR
|
$ 17.02 | -0.96 % | $ 180 M | Nasdaq Global Market | China |
 |
NeoGenomics
NEO
|
$ 8.86 | -1.56 % | $ 1.13 B | Nasdaq Global Select Market,SPB | USA |
 |
Neogen Corporation
NEOG
|
$ 9.27 | 1.98 % | $ 2.01 B | Nasdaq Global Select Market,SPB | USA |
 |
National Research Corporation
NRC
|
$ 18.74 | 2.85 % | $ 419 M | Nasdaq Global Select Market | USA |
 |
Natera
NTRA
|
$ 206.77 | -2.26 % | $ 20.3 B | Nasdaq Global Select Market,SPB | USA |
 |
Quest Diagnostics Incorporated
DGX
|
$ 190.84 | -0.34 % | $ 21.2 B | NYSE,SPB | USA |
 |
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | USA |
 |
Organovo Holdings
ONVO
|
- | -2.3 % | $ 19.4 M | Nasdaq Capital Market | USA |
 |
OpGen
OPGN
|
- | -16.95 % | $ 1.54 M | Nasdaq Capital Market | USA |
 |
PerkinElmer
PKI
|
- | -0.91 % | $ 14.7 B | NYSE,SPB | USA |
 |
Exagen
XGN
|
$ 3.09 | -0.32 % | $ 66.6 M | Nasdaq Global Market | USA |
 |
Precipio
PRPO
|
$ 32.37 | 8.99 % | $ 52 M | Nasdaq Global Select Market | USA |
 |
Personalis
PSNL
|
$ 5.56 | -5.76 % | $ 329 M | Nasdaq Global Select Market | USA |